REVA Medical Inc.
5751 Copley Drive
Suite B
San Diego
California
92111
United States
Tel: 858-430-0720
Fax: 858-430-0729
Website: http://www.teamreva.com/
Email: info@teamreva.com
92 articles about REVA Medical Inc.
-
REVA Medical Announces Initiation of Enrollment in the MOTIV IDE Clincial Trial
9/27/2022
REVA Medical, LLC, a leader in bioresorbable polymer technologies for vascular applications, announced that enrollment in the MOTIV pivotal trial has been initiated at clinical centers in both the U.S. and Europe.
-
REVA Medical Announces Closing of Strategic Financing - Aug 09, 2022
8/9/2022
REVA Medical, LLC., a leader in bioresorbable polymer technologies for vascular applications, is pleased to announce the closing of a $45 million Series B equity financing.
-
REVA Announces Appointment of Stephen Oesterle, MD to Board of Directors
2/5/2018
Dr. Oesterle brings significant clinical, medical device and board expertise to REVA.
-
REVA Announces First Implant of the Fantom Bioresorbable Scaffold in Italy
1/25/2018
The procedure was conducted by Dr. Bernardo Cortese at the Fatebenefratelli Hospital in Milan.
-
REVA Medical Reports Third Quarter 2017 Financial Results
11/8/2017
The Company initiated commercial sales of the Fantom bioresorbable scaffold and reported total billings for shipped product of $105,000 with $17,000 of revenue recognized for the third quarter of 2017 compared to no billings or revenue for the same period in 2016.
-
REVA to Hold Third Quarter 2017 Financial Results Call
11/1/2017
The call is scheduled for 2:00 p.m. US PST on Tuesday, November 7, 2017.
-
Reva Medical: New Fantom Data Demonstrates Safety at 2 Years
11/1/2017
The Company also revealed plans for its next generation scaffold, named Fantom Encore.
-
REVA Announces Commercial Expansion and the First Implant of the Fantom Bioresorbable Scaffold in Switzerland
10/16/2017
REVA Medical announced the commercial expansion of its bioresorbable scaffold (“BRS”), Fantom, with the first implant in Switzerland.
-
REVA Medical Announces Ray Larkin Jr. As Chairman Of The Board Of Directors
9/20/2017
-
REVA Medical to Market Fantom Scaffold Directly After Boston Scientific Failed to Exercise Option to Distribute
8/4/2017
-
REVA Medical Cuts Jobs, Shakes Up C-Suite
7/17/2017
-
San Diego's REVA Medical Completes $34.6 Million Funding Round
6/20/2017
-
REVA Medical Symposium Showcases Clinical Data
5/18/2017
-
REVA Medical Announces Positive 12-Month Clinical Results
5/17/2017
-
REVA Medical Arranges Convertible Note Financing
4/25/2017
-
REVA Medical Receives CE Mark For Fantom
4/4/2017
-
REVA Medical Release: Submission Of CE Mark Application
8/3/2016
-
REVA Medical Achieves Target Patient Enrollment In FANTOM II Trial
2/24/2016
-
REVA Medical Release: Richard Kimes Hired As SVP Of Operations
1/19/2016
-
REVA Medical Considers IPOing Next Year
11/23/2015